In order to investigate the association of fibrin monomer polymerization function (FMPF) with traditional cerebrovascular risk factors and ischemic cerebrovascular disease in old people. 1∶1 paired case-control compa...In order to investigate the association of fibrin monomer polymerization function (FMPF) with traditional cerebrovascular risk factors and ischemic cerebrovascular disease in old people. 1∶1 paired case-control comparative study was performed for FMPF and traditional cerebrovascular risk factors on 110 cases of old ischemic cerebrovascular disease and 110 controls matched on age, sex and living condition. The results showed that cerebrovascular risk factors were more prevalent in case group than in control group. In the case group, FMPF was significantly higher than in control group. There was a significant positive correlation between hypertension and fibrin monomer polymerization velocity (FMPV), hypertension and fibrinogen (Fbg), alcohol consumption and Fbg, but no significant correlation between diabetic mellitus, smoking and FMPF was found. Among the parameters of blood lipids, there were significant positive correlations between total cholesterol (TC) and parameters of FMPF to varying degrees, triglycerides (TG) and FMPV, TG and Fbg. Our results also showed there were significant linear trends between TC and FMPV (P<0. 001), TC and Fbg (P=0. 0087), TG and FMPV/Amax (maximum absorbance)(P=0. 0143) respectively. Multiple logistic regression analysis revealed that FMPF in case group remained significantly higher than control group after adjustment of all risk factors that were significant in univariate analysis. It was concluded that there is a possible pathophysiological link between FMPF and cerebrovascular risk factors. An elevated FMPF is associated with ischemic cerebrovascular disease and an independent risk factor of this disease. In old people, detection of FMPF might be a useful screening to identify individuals at increased cerebrothrombotic risk.展开更多
Objective: To explore the effects of the somatosensory interaction technology combined with virtual reality technology on upper limbs function and activities of daily living (ADL) in cerebrovascular disease patients. ...Objective: To explore the effects of the somatosensory interaction technology combined with virtual reality technology on upper limbs function and activities of daily living (ADL) in cerebrovascular disease patients. Methods: Form January, 2019 to December, 2019, 80 cerebrovascular disease patients were recruited, and had been divided into control group (n = 40) and observation group (n = 40), randomly. The control groups received conventional rehabilitation treatment, for 40 minutes per day, while observation group received conventional rehabilitation treatment, for 20 minutes per day, and virtual reality technology treatment, 20 minutes per day, 5 days a week for 4 weeks. Wolf Motor Function Test (WMFT), Fugl-Meyer Assessment-Upper Extremities (FMA-UE) and modified Barthel index (MBI) were used to assess the motor function of the upper limbs and ADL before and after treatment. Results: Before treatment, the scores of WMFT, FMA-UE and MBI were no significant difference between two groups (P > 0.05). The scores improved in both groups after treatment (P < 0.01), and were higher in the observation group than in the control group (P < 0.05). Conclusion: The somatosensory interaction technology combined with virtual reality technology could facilitate to improve the upper limbs function and ADL in cerebrovascular disease patients.展开更多
Alzheimer's disease(AD) is a progressive and degenerative neurological disease characterized by the deterioration of cognitive functions. While a definitive cure and optimal medication to impede disease progressio...Alzheimer's disease(AD) is a progressive and degenerative neurological disease characterized by the deterioration of cognitive functions. While a definitive cure and optimal medication to impede disease progression are currently unavailable, a plethora of studies have highlighted the potential advantages of exercise rehabilitation for managing this condition. Those studies show that exercise rehabilitation can enhance cognitive function and improve the quality of life for individuals affected by AD. Therefore, exercise rehabilitation has been regarded as one of the most important strategies for managing patients with AD. Herein, we provide a comprehensive analysis of the currently available findings on exercise rehabilitation in patients with AD, with a focus on the exercise types which have shown efficacy when implemented alone or combined with other treatment methods, as well as the potential mechanisms underlying these positive effects. Specifically, we explain how exercise may improve the brain microenvironment and neuronal plasticity. In conclusion, exercise is a cost-effective intervention to enhance cognitive performance and improve quality of life in patients with mild to moderate cognitive dysfunction. Therefore, it can potentially become both a physical activity and a tailored intervention. This review may aid the development of more effective and individualized treatment strategies to address the challenges imposed by this debilitating disease, especially in low-and middle-income countries.展开更多
目的探讨奥拉西坦联合丁苯酞对非痴呆型血管性认知障碍(vascular cognitive impairment of non-dementia,VCIND)患者的临床疗效。方法将64例VCIND患者随机分为对照组与联合组,每组32例。2组均接受常规治疗,对照组给予奥拉西坦治疗,联合...目的探讨奥拉西坦联合丁苯酞对非痴呆型血管性认知障碍(vascular cognitive impairment of non-dementia,VCIND)患者的临床疗效。方法将64例VCIND患者随机分为对照组与联合组,每组32例。2组均接受常规治疗,对照组给予奥拉西坦治疗,联合组给予奥拉西坦联合丁苯酞治疗,疗程为3个月。比较2组患者治疗前后蒙特利尔认知评估量表(Montreal cognitive assessment scale,MoCA)评分、简易精神状态评价量表(mini mental state evaluation scale,MMSE)、美国国立卫生院卒中量表(national institutes of health stroke scale,NIHSS)评分和日常生活活动能力量表(activity of daily living scale,ADL)评分,检测血清转化生长因子-β(transforming growth factor-β,TGF-β)、基质金属蛋白酶-9(matrix metalloproteinase-9,MMP-9)、抗凋亡因子(anti-apoptotic factor,Livin)、神经元特异性烯醇化酶(neuron-specific enolase,NSE)和神经生长因子(nerve growth factor,NGF)水平的变化,检测脑血管平均血流速度(mean velocity,V_(m))、动脉搏动指数(pulsatility index,PI)与阻力指数(resistance index,RI)。结果治疗后,2组MoCA、MMSE和ADL评分均升高,NIHSS评分均降低,且联合组MoCA、MMSE和ADL评分显著高于对照组(P<0.05)。2组脑血管V_(m)均升高,PI和RI均降低,且联合组显著优于对照组(P<0.05);2组血清MMP-9NSE均降低,TGF-β、Livin和NGF水平均升高,且联合组显著优于对照组(P<0.05)。结论奥拉西坦联合丁苯酞治疗VCIND可有效改善患者的脑血管功能,保护神经功能及认知功能,其机制可能与纠正血清TGF-β、MMP-9、Livin、NSE及NGF水平有关。展开更多
目的探讨急性缺血性脑血管病单纯应用静脉溶栓与联合应用静脉溶栓与血管内介入治疗的疗效对比。方法回顾性选取2021年3月—2022年3月南京市浦口人民医院收治的60例急性缺血性脑血管病患者的临床资料。按照不同治疗方法将患者分为联合组...目的探讨急性缺血性脑血管病单纯应用静脉溶栓与联合应用静脉溶栓与血管内介入治疗的疗效对比。方法回顾性选取2021年3月—2022年3月南京市浦口人民医院收治的60例急性缺血性脑血管病患者的临床资料。按照不同治疗方法将患者分为联合组(30例)和单药组(30例),分别给予静脉溶栓联合血管内介入治疗和单纯静脉溶栓治疗。比较两组患者血液流变学指标、美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分、改良Rankin量表(Modified Rankin Scale,MRS)评分及不良血管事件的发生率。结果治疗后,联合组血浆黏度、红细胞聚集指数(1.91±0.16)mPa/s、(4.53±0.82)低于单药组(2.42±0.23)mPa/s、(5.14±1.16),差异有统计学意义(t=9.970、2.352,P均<0.05)。治疗后,联合组NIHSS、MRS评分明显低于单药组,差异有统计学意义(P均<0.05)。联合组不良血管事件发生率明显低于单药组,差异有统计学意义(P<0.05)。结论在急性缺血性脑血管病的临床治疗中,采用静脉溶栓与血管内介入联合治疗的方案,患者预后改善效果明显优于单纯静脉溶栓治疗,且不良血管事件发生率低。展开更多
文摘In order to investigate the association of fibrin monomer polymerization function (FMPF) with traditional cerebrovascular risk factors and ischemic cerebrovascular disease in old people. 1∶1 paired case-control comparative study was performed for FMPF and traditional cerebrovascular risk factors on 110 cases of old ischemic cerebrovascular disease and 110 controls matched on age, sex and living condition. The results showed that cerebrovascular risk factors were more prevalent in case group than in control group. In the case group, FMPF was significantly higher than in control group. There was a significant positive correlation between hypertension and fibrin monomer polymerization velocity (FMPV), hypertension and fibrinogen (Fbg), alcohol consumption and Fbg, but no significant correlation between diabetic mellitus, smoking and FMPF was found. Among the parameters of blood lipids, there were significant positive correlations between total cholesterol (TC) and parameters of FMPF to varying degrees, triglycerides (TG) and FMPV, TG and Fbg. Our results also showed there were significant linear trends between TC and FMPV (P<0. 001), TC and Fbg (P=0. 0087), TG and FMPV/Amax (maximum absorbance)(P=0. 0143) respectively. Multiple logistic regression analysis revealed that FMPF in case group remained significantly higher than control group after adjustment of all risk factors that were significant in univariate analysis. It was concluded that there is a possible pathophysiological link between FMPF and cerebrovascular risk factors. An elevated FMPF is associated with ischemic cerebrovascular disease and an independent risk factor of this disease. In old people, detection of FMPF might be a useful screening to identify individuals at increased cerebrothrombotic risk.
文摘Objective: To explore the effects of the somatosensory interaction technology combined with virtual reality technology on upper limbs function and activities of daily living (ADL) in cerebrovascular disease patients. Methods: Form January, 2019 to December, 2019, 80 cerebrovascular disease patients were recruited, and had been divided into control group (n = 40) and observation group (n = 40), randomly. The control groups received conventional rehabilitation treatment, for 40 minutes per day, while observation group received conventional rehabilitation treatment, for 20 minutes per day, and virtual reality technology treatment, 20 minutes per day, 5 days a week for 4 weeks. Wolf Motor Function Test (WMFT), Fugl-Meyer Assessment-Upper Extremities (FMA-UE) and modified Barthel index (MBI) were used to assess the motor function of the upper limbs and ADL before and after treatment. Results: Before treatment, the scores of WMFT, FMA-UE and MBI were no significant difference between two groups (P > 0.05). The scores improved in both groups after treatment (P < 0.01), and were higher in the observation group than in the control group (P < 0.05). Conclusion: The somatosensory interaction technology combined with virtual reality technology could facilitate to improve the upper limbs function and ADL in cerebrovascular disease patients.
基金supported by the National Natural Science Foundation of China,Nos.81971309 (to CY),32170980 (to CY),82260272 (to DL)the Natural Science Foundation of Jiangxi Province,No.20192BAB205078 (to DL)+1 种基金Guangdong Basic and Applied Basic Research Foundation,No.2022B1515020012 (to CY)Shenzhen Fundamental Research Program,Nos.JCYJ20210324123212035 (to CY),RCYX202007141 14644167 (to CY),ZDSYS20220606100801003 (to CY)。
文摘Alzheimer's disease(AD) is a progressive and degenerative neurological disease characterized by the deterioration of cognitive functions. While a definitive cure and optimal medication to impede disease progression are currently unavailable, a plethora of studies have highlighted the potential advantages of exercise rehabilitation for managing this condition. Those studies show that exercise rehabilitation can enhance cognitive function and improve the quality of life for individuals affected by AD. Therefore, exercise rehabilitation has been regarded as one of the most important strategies for managing patients with AD. Herein, we provide a comprehensive analysis of the currently available findings on exercise rehabilitation in patients with AD, with a focus on the exercise types which have shown efficacy when implemented alone or combined with other treatment methods, as well as the potential mechanisms underlying these positive effects. Specifically, we explain how exercise may improve the brain microenvironment and neuronal plasticity. In conclusion, exercise is a cost-effective intervention to enhance cognitive performance and improve quality of life in patients with mild to moderate cognitive dysfunction. Therefore, it can potentially become both a physical activity and a tailored intervention. This review may aid the development of more effective and individualized treatment strategies to address the challenges imposed by this debilitating disease, especially in low-and middle-income countries.
文摘目的探讨急性缺血性脑血管病单纯应用静脉溶栓与联合应用静脉溶栓与血管内介入治疗的疗效对比。方法回顾性选取2021年3月—2022年3月南京市浦口人民医院收治的60例急性缺血性脑血管病患者的临床资料。按照不同治疗方法将患者分为联合组(30例)和单药组(30例),分别给予静脉溶栓联合血管内介入治疗和单纯静脉溶栓治疗。比较两组患者血液流变学指标、美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分、改良Rankin量表(Modified Rankin Scale,MRS)评分及不良血管事件的发生率。结果治疗后,联合组血浆黏度、红细胞聚集指数(1.91±0.16)mPa/s、(4.53±0.82)低于单药组(2.42±0.23)mPa/s、(5.14±1.16),差异有统计学意义(t=9.970、2.352,P均<0.05)。治疗后,联合组NIHSS、MRS评分明显低于单药组,差异有统计学意义(P均<0.05)。联合组不良血管事件发生率明显低于单药组,差异有统计学意义(P<0.05)。结论在急性缺血性脑血管病的临床治疗中,采用静脉溶栓与血管内介入联合治疗的方案,患者预后改善效果明显优于单纯静脉溶栓治疗,且不良血管事件发生率低。